HCPLive

SEPTEMBER 27, 2024

The approval to GE Healthcare's cyclotron-produced radioactive diagnostic drug provides another option to adequately identify significant coronary artery disease.

Coronary Artery Disease 52

Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

MARCH 7, 2024

The 2017 World Health Organization Fact Sheet highlights that coronary artery disease is the leading cause of death globally, responsible for approximately 30% of all deaths. In this context, machine learning (ML) technology is crucial in identifying coronary artery disease, thereby saving lives.

Coronary Artery Disease 111

Coronary Artery Disease Biomarkers Technology Outcomes 111

Heart BMJ

NOVEMBER 19, 2024

Objective To evaluate the association between results of stress echocardiography and patients’ outcomes with suspected coronary artery disease using randomised controlled trials. A common-effect model was used to derive pooled estimates. PROSPERO registration number CRD42023416766.

Coronary Artery Disease 52

Coronary Artery Disease Myocardial Infarction Pharmacology Outcomes 52

Cardiovascular Diabetology

OCTOBER 27, 2024

Diabetes mellitus (DM) is associated with premature atherosclerotic disease, coronary artery disease (CAD) and chronic heart failure (HF), leading to increased morbidity and mortality. Sodium-Glucose Co-transp.

Coronary Artery Disease 59

Coronary Artery Disease Diabetes Circulation Heart Failure 59

Cardiology Update

MARCH 4, 2024

The optimal surveillance strategy after percutaneous coronary intervention (PCI) for high-risk patients with multivessel or left main coronary artery disease (CAD) remains uncertain. The post POST-PCI Surveillance Strategies for Multivessel or Left Main Coronary Artery Disease appeared first on Cardiology Update.

Coronary Artery Disease 111

Coronary Artery Disease Myocardial Infarction Angina Article 111

DAIC

JULY 18, 2024

HeartFlow’s Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. F.A.C.C.

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Medicare 111

JAMA Cardiology

NOVEMBER 5, 2024

This genomewide association study examined specific genetic variants, pathways, and tissues associated with aortic stenosis independent of coronary artery disease in a meta-analysis of participants from 3 European cohorts.

Coronary Artery Disease 40

Coronary Artery Disease Stenosis Aortic 40

Cardiovascular Diabetology

FEBRUARY 23, 2024

Insulin resistance (IR) is associated with coronary artery disease (CAD) severity. However, its underlying mechanisms are not fully understood. Therefore, our study aimed to explore the relationship between IR.

Coronary Artery Disease 95

Coronary Artery Disease Research 95

Dr. Paddy Barrett

DECEMBER 19, 2023

Reversing or regressing coronary artery disease is possible. But can coronary artery disease be reversed with lifestyle measures, including changes to nutrition and exercise? Subscribe now 1 Pathophysiology of Coronary Artery Disease. In: Yuan, C., Hatsukami, T., Mossa-Basha, M.

Coronary Artery Disease 105

Coronary Artery Disease Plaque Exercise Heart Attack 105

The New England Journal of Medicine

AUGUST 31, 2024

In patients with stable vascular disease without atrial fibrillation, antiplatelet therapy is recommended. However, atrial fibrillation commonly coexists with vascular diseases, such as coronary artery disease. When patients with both conditions present with.

Coronary Artery Disease 40

Coronary Artery Disease Atrial Fibrillation Stroke Strokes 40

Cardiovascular Diabetology

JUNE 20, 2024

Various surrogate markers of insulin resistance have been developed, capable of predicting coronary artery disease (CAD) without the need to detect serum insulin. For accurate prediction, they depend only on g.

Coronary Artery Disease 59

Coronary Artery Disease Research 59

Journal of Cardiothoracic Surgery

SEPTEMBER 11, 2024

Congenital Quadricuspid Aortic Valve (QAV) malformation is a relatively rare cardiac valve malformation, especially with abnormal coronary opening and severe stenosis of Coronary Artery Disease (CAD). The pati.

Coronary Artery Disease 52

Coronary Artery Disease Aortic valve Aortic Congenital 52

DAIC

MARCH 27, 2024

The registry will collect multi-site, real-world information on how the Plaque Analysis product provides enhanced patient insights, empowering physicians and helping to inform their medical management decisions for patients with suspected coronary artery disease (CAD).

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Anatomy 111

Circulation

NOVEMBER 11, 2024

Out of these, 162 patients had chronic coronary artery disease (CAD), while the remaining 62 patients were free of CAD. A total of 162 patients with chronic coronary artery disease (CAD) were monitored for cardiovascular disease (CVD) events over a period of 2 years.Results:CAVI in chronic CAD patients (9.21±0.79)

Coronary Artery Disease 40

Coronary Artery Disease Cardiovascular Disease Stenosis Blood Pressure 40

Medical Xpress - Cardiology

JANUARY 9, 2024

A research team has demonstrated the clinical feasibility and safety of non-contrast optical coherence tomography (OCT) for patients with coronary artery disease.

Coronary Artery Disease 86

Coronary Artery Disease Research 86

HCPLive

OCTOBER 17, 2024

This analysis was conducted to evaluate whether genetic risk of hidradenitis suppurativa was linked to greater risk of future cardiometabolic disease.

Coronary Artery Disease 111

Coronary Artery Disease Diabetes 111

Cardiovascular Diabetology

AUGUST 6, 2024

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry.

Coronary Artery Disease 98

Coronary Artery Disease Diabetes Myocardial Infarction Heart Failure 98

American College of Cardiology

MARCH 12, 2024

The goal of the DISCHARGE trial was to evaluate computed tomography (CT) compared with invasive coronary angiography among patients with stable chest pain and intermediate pretest probability of obstructive coronary artery disease.

Coronary Artery Disease 64

Coronary Artery Disease Chest Pain Article 64

Medical Xpress - Cardiology

SEPTEMBER 3, 2024

Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients with stable coronary artery disease (CAD) and severe aortic stenosis selected for transcatheter aortic valve implantation (TAVI), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Coronary Artery Disease 40

Coronary Artery Disease Aortic valve Aortic Stenosis 40

Cardiovascular Diabetology

MAY 30, 2024

Ischemia and no obstructive coronary artery disease (INOCA) is increasingly recognized and associated with poor outcomes. The triglyceride-glucose (TyG) index is a reliable alternative measure of insulin resis.

Coronary Artery Disease 59

Coronary Artery Disease Ischemia Outcomes Research 59

Journal of Cardiothoracic Surgery

MAY 6, 2024

The long-term prognosis of patients with coronary artery disease (CAD) with diffuse long lesion underwent coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI) remains worse. Here, we.

Coronary Artery Disease 52

Coronary Artery Disease Coronary Artery Bypass Graft Research 52

Frontiers in Cardiovascular Medicine

JUNE 30, 2024

ObjectiveThis study focuses on the innovative application of Automated Machine Learning (AutoML) technology in cardiovascular medicine to construct an explainable Coronary Artery Disease (CAD) prediction model to support the clinical diagnosis of CAD.MethodsThis study utilizes a combined data set of five public data sets related to CAD.

Coronary Artery Disease 52

Coronary Artery Disease Technology Innovation 52

American College of Cardiology

MARCH 5, 2024

Kramer, MD, FACC, discuss From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs. In this interview, Jonathan R. Weir-McCall, PhD, and Christopher M.

Coronary Artery Disease 57

Coronary Artery Disease Outcomes Article 57

Frontiers in Cardiovascular Medicine

FEBRUARY 18, 2024

Drug-eluting stents (DES) play a crucial role in treating coronary artery disease (CAD) by preventing restenosis. Frequently recurring keywords in this research landscape include DES coronary artery disease, percutaneous coronary intervention, implantation, and restenosis.

Coronary Artery Disease 59

Coronary Artery Disease Stents Stent Research 59

Circulation

NOVEMBER 11, 2024

Background:Associations of anxiety disorder and depression with coronary artery disease (CAD) are heterogeneous between populations.Research questions:How does genetic susceptibility to CAD alter the associations between anxiety and depression and incident CAD?Aims:To

Coronary Artery Disease 40

Coronary Artery Disease Certification Hospital Circulation 40

Cardiovascular Diabetology

JULY 12, 2024

The triglyceride-glucose (TyG) index is associated with the development and prognosis of coronary artery disease (CAD). However, the impact of the TyG index on CAD severity across different glucose metabolism.

Coronary Artery Disease 59

Coronary Artery Disease Research 59

Cardiovascular Diabetology

AUGUST 6, 2024

The impact of rosuvastatin versus atorvastatin on new-onset diabetes mellitus (NODM) among patients treated with high-intensity statin therapy for coronary artery disease (CAD) remains to be clarified. This st.

Coronary Artery Disease 59

Coronary Artery Disease Diabetes Research 59

Journal of Cardiovascular Pharmacology

NOVEMBER 11, 2024

Patients with ST-segment elevation myocardial infarction (STEMI) and complex coronary artery disease (CAD) face a poor prognosis, including increased heart failure (HF) risk.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Heart Failure 40

Open Heart

MARCH 29, 2024

Coronary artery disease (CAD) is frequently found in this patient group and optimal management in these patients remains uncertain. Background Aortic stenosis is a life-limiting condition for which transcatheter aortic valve implantation (TAVI) is an established therapy.

Coronary Artery Disease 52

Coronary Artery Disease Aortic valve Aortic Outcomes 52

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

Objective In patients with complex coronary artery disease (CAD) undergoing cardiac surgery, myocardial protection might be impaired due to microvascular obstruction, resulting in myocardial injury and subsequent biomarker release.

Coronary Artery Disease 64

Coronary Artery Disease Biomarkers Outcomes 64

The British Journal of Cardiology

MARCH 7, 2024

The National Institute for Health and Care Excellence (NICE) advise against routine testing for coronary artery disease (CAD) in patients with non-anginal chest pain (NACP). Over 23 months, 866 patients with NACP underwent CTCA.

Coronary Artery Disease 52

Coronary Artery Disease Chest Pain Risk Factors Hypertension 52

DAIC

FEBRUARY 13, 2024

It further reported that these results underscore the strong and positive effect of the Cleerly products on clinical utility for patients with suspected coronary artery disease. “We AJR Am J Roentgenol 2022 Sep;219(3):407-419. 7 Bär S, Nabeta T, Maaniitty T. Eur Heart J Cardiovasc Imaging. 2023 Dec 12:jead339. PMID: 38084894.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

Open Heart

OCTOBER 1, 2024

Background The prognosis of myocardial ischaemia with no obstructive coronary artery disease (INOCA) and its underlying vasomotor disorders, vasospastic angina (VSA) and microvascular angina (MVA), is not well defined.

Coronary Artery Disease 52

Coronary Artery Disease Outcomes Angina Myocardial Infarction 52

DAIC

MAY 14, 2024

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

Cardiovascular Diabetology

FEBRUARY 23, 2024

Intensive glycemic control reduced coronary artery disease (CAD) events among the Action to Control Cardiovascular Disease Risk in Diabetes (ACCORD) participants with the haptoglobin (Hp) 2-2 phenotype only.

Coronary Artery Disease 52

Coronary Artery Disease Diabetes Cardiovascular Disease Research 52

Circulation

NOVEMBER 11, 2024

A random-effects model was used for outcomes with high heterogeneity.Results:We included 4 RCTs with 3173 patients comparing FFR-guided CR with culprit-only PCI in patients with STEMI and multivessel coronary artery diseases. The pooled results of the 4 RCTs showed that MACE (RR=0.66; 95% CI [0.45, 0.99]; p=0.01; 16.8%

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Thrombosis 40

HeartRhythm

APRIL 30, 2024

Coronary artery disease (CAD) is a leading cause of mortality worldwide. It slows ventricular conduction and increases dispersion of repolarization, manifesting differently on the electrocardiogram (ECG).

Coronary Artery Disease 40

Coronary Artery Disease Heart Failure Electrocardiogram 40